Siga Technologies (SIGA) Total Current Liabilities (2010 - 2025)
Siga Technologies' (SIGA) quarterly Total Current Liabilities came in at $18.0 million in Q4 2025, down 28.97% YoY from $25.3 million in Q4 2024, and down 27.57% on a QoQ basis from $24.8 million in Q3 2025.
Siga Technologies (SIGA) Total Current Liabilities (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Total Current Liabilities data on file, last reported at $18.0 million in Q4 2025.
- Quarterly Total Current Liabilities fell 28.97% year-over-year to $18.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.0 million (down 28.97% YoY) and the FY2025 annual result came in at $18.0 million, down 28.97% from the prior year.
- Total Current Liabilities fell to $18.0 million in Q4 2025, from $24.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $74.8 million in Q1 2024 to a low of $7.2 million in Q1 2022.
- A 5-year average of $24.9 million and a median of $21.9 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities sank 64.94% — and 2024, when it soared 304.9%.
- Tracing SIGA's Total Current Liabilities over 5 years: stood at $30.5 million in 2021, then declined by 29.42% to $21.5 million in 2022, then surged by 151.5% to $54.1 million in 2023, then slumped by 53.19% to $25.3 million in 2024, then dropped by 28.97% to $18.0 million in 2025.
- The last three Total Current Liabilities figures came in at $18.0 million (Q4 2025), $24.8 million (Q3 2025), and $22.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - | 17.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.99 Mn |
| Sep 30, 2025 | 24.84 Mn |
| Jun 30, 2025 | 22.72 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 25.33 Mn |
| Sep 30, 2024 | 22.30 Mn |
| Jun 30, 2024 | 21.38 Mn |
| Mar 31, 2024 | 74.81 Mn |
| Dec 31, 2023 | 54.12 Mn |
| Sep 30, 2023 | 30.74 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 21.52 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | 16.69 Mn |
| Mar 31, 2022 | 7.24 Mn |
| Dec 31, 2021 | 30.49 Mn |
| Sep 30, 2021 | 18.94 Mn |
| Jun 30, 2021 | 7.97 Mn |
| Mar 31, 2021 | 7.51 Mn |